Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,079,680    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $65,018,530      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $910,988 Immunome Inc. $140,283 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $910,988 Immunome Inc. $140,283
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 34 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-30 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-13 4 OE $38.59 $2,050,094 D/D 53,125 376,493 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-13 4 AS $86.98 $4,620,563 D/D (53,125) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 A $0.00 $0 D/D 56,000 169,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-05 4 OE $12.99 $779,400 I/I 60,000 20,000 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-27 4 AS $81.34 $4,880,448 D/D (60,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-27 4 OE $14.39 $863,400 D/D 60,000 383,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-28 4 AS $81.27 $4,875,990 D/D (60,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-28 4 OE $14.39 $863,400 D/D 60,000 383,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-15 4 A $0.00 $0 D/D 60,710 392,221 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-22 4 AS $85.69 $5,976,515 D/D (69,743) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-22 4 OE $26.49 $1,847,492 D/D 69,743 240,425 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-21 4 AS $87.56 $6,106,478 D/D (69,744) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-21 4 OE $26.49 $1,847,519 D/D 69,744 240,426 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-07 4 AS $82.52 $5,776,435 D/D (70,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-07 4 OE $21.51 $1,505,700 D/D 70,000 393,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-08 4 AS $82.83 $5,797,806 D/D (70,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-08 4 OE $21.51 $1,505,700 D/D 70,000 393,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-02-14 4 A $0.00 $0 D/D 78,750 194,520 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-03-15 4 D $83.87 $7,146,479 D/D (85,209) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-16 4 D $93.41 $8,278,274 D/D (88,623) 425,896 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-16 4 AS $95.25 $9,058,600 D/D (94,791) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-16 4 OE $17.54 $2,780,915 D/D 94,791 420,250 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-27 4 A $0.00 $0 D/D 143,601 563,203 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-28 4 A $0.00 $0 D/D 167,532 487,856 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34  35      
  Page 34 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us